Aveanna Healthcare (NASDAQ:AVAH) CAO Deborah Stewart Sells 11,379 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,379 shares of the stock in a transaction dated Tuesday, December 30th. The stock was sold at an average price of $8.36, for a total transaction of $95,128.44. Following the sale, the chief accounting officer owned 274,913 shares of the company’s stock, valued at approximately $2,298,272.68. This represents a 3.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Deborah Stewart also recently made the following trade(s):

• On Friday, January 2nd, Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $93,901.70.
• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total value of $92,229.50.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $8.08 on Friday. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. The stock has a fifty day moving average of $8.92 and a 200 day moving average of $7.49. Aveanna Healthcare Holdings Inc. has a 52 week low of $3.67 and a 52 week high of $10.32. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The business had revenue of $450.53 million for the quarter. As a group, research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have weighed in on AVAH shares. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. William Blair began coverage on Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating on the stock. Truist Financial increased their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. UBS Group raised their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. Finally, BMO Capital Markets initiated coverage on shares of Aveanna Healthcare in a research report on Thursday, November 13th. They issued an “outperform” rating and a $11.00 target price on the stock. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $10.69.

More Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors and hedge funds have recently modified their holdings of AVAH. Banque Transatlantique SA bought a new position in Aveanna Healthcare in the 1st quarter worth about $25,000. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the 2nd quarter valued at about $43,000. Diversified Trust Co purchased a new position in Aveanna Healthcare in the second quarter worth about $57,000. Jump Financial LLC bought a new position in shares of Aveanna Healthcare in the first quarter worth approximately $59,000. Finally, MQS Management LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter valued at approximately $59,000. 87.96% of the stock is currently owned by institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.